RETRACTED: Pachymic acid activates TP53INP2 / TRAF6 /caspase‐8 pathway to promote apoptosis in renal cell carcinoma cells
Environmental Toxicology · 2025
DOI: 10.1002/tox.24195 ↗Kurz gefasst
Zurückgezogene Publikation in der Zeitschrift Environmental Toxicology, 2025. Verfasst von Xunjia Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Chongqing Hospital of Traditional Chinese Medicine, Chongqing, China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, Triterpenes. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: First-class grants of Special Grants for Postdoctoral Research Projects, Special Project for Performance Incentive and Guidance of Scientific Research Institutions in Chongqing.
Abstract (Originalsprache)
While pachymic acid (PA), a key component of Poria cocos (Schw.) , has demonstrated anti‐tumor effects in lung, breast, and pancreatic cancers, its impact on renal cell carcinoma (RCC) is unclear. This study evaluated the effect of PA on proliferation, migration, and apoptosis in human renal cancer A498 and ACHN cells as well as in cancer xenograft mice using wound scratch test, Western blotting, and co‐immunoprecipitation assays. In a dose‐ and time‐dependent manner, PA exhibited significant inhibition of RCC cell proliferation, migration, and invasion, accompanied by the induction of apoptosis. Additionally, PA upregulated the expression of tumor protein p53‐inducible nuclear protein 2 (TP53INP2) and tumor necrosis factor receptor‐associated factor 6 (TRAF6), which were downregulated in renal papillary and chromophobe carcinoma, resulting in inhibited tumor growth in mice. PA treatment elevated cleaved‐caspase 3 and 8, and PARP levels, and facilitated TP53INP2 and TRAF6 binding to caspase 8, promoting its ubiquitination. Molecular docking revealed interactions between PA and TP53INP2, TRAF6. In summary, PA inhibits RCC development by upregulating TP53INP2 and promoting TRAF6‐induced caspase 8 ubiquitination, activating apoptotic pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Chongqing Hospital of Traditional Chinese Medicine, Chongqing, China.
- Department of Research and Development, Chongqing Precision Medical Industry Technology Research Institute, Chongqing, China.
- Division of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
- Department of Oncology, Chongqing Hospital of Traditional Chinese Medicine, Chongqing, China.
- Department of Rehabilitation Medicine, Chongqing Hospital of Traditional Chinese Medicine, Chongqing, China.
ORCID-Profile: Deyu Zuo
Förderung
- First-class grants of Special Grants for Postdoctoral Research Projects
- Special Project for Performance Incentive and Guidance of Scientific Research Institutions in Chongqing
Zitieren
APA
Li, X., He, A., Liu, C., Li, Y., Luo, Y., Xiong, W., Nian, W., & Zuo, D. (2025). RETRACTED: Pachymic acid activates TP53INP2 / TRAF6 /caspase‐8 pathway to promote apoptosis in renal cell carcinoma cells. Environmental Toxicology. https://doi.org/10.1002/tox.24195
Vancouver
Li X, He A, Liu C, Li Y, Luo Y, Xiong W, et al. RETRACTED: Pachymic acid activates TP53INP2 / TRAF6 /caspase‐8 pathway to promote apoptosis in renal cell carcinoma cells. Environmental Toxicology. 2025. doi:10.1002/tox.24195
BibTeX
@article{Li2025,
author = {Li, Xunjia and He, An and Liu, Chengxuan and Li, Ying and Luo, Yan and Xiong, Weijian and Nian, Weiqi and Zuo, Deyu},
title = {RETRACTED: Pachymic acid activates TP53INP2 / TRAF6 /caspase‐8 pathway to promote apoptosis in renal cell carcinoma cells},
journal = {Environmental Toxicology},
year = {2025},
doi = {10.1002/tox.24195}
}
EUVIMED